Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
61.11 (1y: +56%)
Market Cap 7.75 B P/E(ttm) 19.40
Enterprise Value 7.99 B P/B 4.90
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry		 vs
history
Cash to Debt 4.342
ALIOF's Cash to Debt is ranked lower than
61% of the 392 Companies
in the Global Biotechnology industry.

( Industry Median: 46.63 vs. ALIOF: 4.342 )
ALIOF' s 10-Year Cash to Debt Range
Min: 0.64   Max: No Debt
Current: 4.34
Equity to Asset 0.473
ALIOF's Equity to Asset is ranked lower than
55% of the 392 Companies
in the Global Biotechnology industry.

( Industry Median: 0.53 vs. ALIOF: 0.473 )
ALIOF' s 10-Year Equity to Asset Range
Min: 0.23   Max: 0.51
Current: 0.47
0.23
0.51
Interest Coverage 8.1
ALIOF's Interest Coverage is ranked lower than
58% of the 392 Companies
in the Global Biotechnology industry.

( Industry Median: 37.90 vs. ALIOF: 8.1 )
ALIOF' s 10-Year Interest Coverage Range
Min: 1   Max: No Debt
Current: 8.1
F-Score: 7
Z-Score: 5.89
M-Score: -4.58
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry		 vs
history
Operating margin (%) 24.40
ALIOF's Operating margin (%) is ranked higher than
89% of the 392 Companies
in the Global Biotechnology industry.

( Industry Median: -31.50 vs. ALIOF: 24.40 )
ALIOF' s 10-Year Operating margin (%) Range
Min: 0.7   Max: 28.4
Current: 24.4
0.7
28.4
Net-margin (%) 17.5
ALIOF's Net-margin (%) is ranked higher than
86% of the 392 Companies
in the Global Biotechnology industry.

( Industry Median: -29.90 vs. ALIOF: 17.5 )
ALIOF' s 10-Year Net-margin (%) Range
Min: -8.1   Max: 25.5
Current: 17.5
-8.1
25.5
ROE (%) 20
ALIOF's ROE (%) is ranked higher than
91% of the 392 Companies
in the Global Biotechnology industry.

( Industry Median: -7.60 vs. ALIOF: 20 )
ALIOF' s 10-Year ROE (%) Range
Min: -9.7   Max: 55.2
Current: 20
-9.7
55.2
ROA (%) 11.3
ALIOF's ROA (%) is ranked higher than
88% of the 392 Companies
in the Global Biotechnology industry.

( Industry Median: -10.10 vs. ALIOF: 11.3 )
ALIOF' s 10-Year ROA (%) Range
Min: -5.4   Max: 17.6
Current: 11.3
-5.4
17.6
ROC (Joel Greenblatt) (%) 76.50
ALIOF's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 392 Companies
in the Global Biotechnology industry.

( Industry Median: 0.00 vs. ALIOF: 76.50 )
ALIOF' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 2   Max: 2089.3
Current: 76.5
2
2089.3
Revenue Growth (%) 0.3
ALIOF's Revenue Growth (%) is ranked higher than
65% of the 392 Companies
in the Global Biotechnology industry.

( Industry Median: 0.00 vs. ALIOF: 0.3 )
ALIOF' s 10-Year Revenue Growth (%) Range
Min: -20.1   Max: 15.7
Current: 0.3
-20.1
15.7
EBITDA Growth (%) 5.6
ALIOF's EBITDA Growth (%) is ranked higher than
80% of the 392 Companies
in the Global Biotechnology industry.

( Industry Median: 0.00 vs. ALIOF: 5.6 )
ALIOF' s 10-Year EBITDA Growth (%) Range
Min: -27.5   Max: 41.5
Current: 5.6
-27.5
41.5
EPS Growth (%) 0.4
ALIOF's EPS Growth (%) is ranked higher than
78% of the 392 Companies
in the Global Biotechnology industry.

( Industry Median: 0.00 vs. ALIOF: 0.4 )
ALIOF' s 10-Year EPS Growth (%) Range
Min: -30.1   Max: 34
Current: 0.4
-30.1
34
ยป ALIOF's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

ALIOF Guru Trades in

ALIOF Guru Trades in

Q2 2012

ALIOF Guru Trades in Q2 2012

Vanguard Health Care Fund 200,000 sh (New)
» More
Q3 2012

ALIOF Guru Trades in Q3 2012

Vanguard Health Care Fund 200,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with ALIOF



No Insider Trades Found!

Ratios

vs
industry		 vs
history
P/E(ttm) 19.40
ALIOF's P/E(ttm) is ranked higher than
72% of the 155 Companies
in the Global Biotechnology industry.

( Industry Median: 32.70 vs. ALIOF: 19.40 )
ALIOF' s 10-Year P/E(ttm) Range
Min: 13.52   Max: 24.05
Current: 19.4
13.52
24.05
P/B 4.90
ALIOF's P/B is ranked lower than
61% of the 359 Companies
in the Global Biotechnology industry.

( Industry Median: 3.76 vs. ALIOF: 4.90 )
ALIOF' s 10-Year P/B Range
Min: 2.41   Max: 5.31
Current: 4.9
2.41
5.31
P/S 3.98
ALIOF's P/S is ranked higher than
70% of the 391 Companies
in the Global Biotechnology industry.

( Industry Median: 7.70 vs. ALIOF: 3.98 )
ALIOF' s 10-Year P/S Range
Min: 1.96   Max: 4.2
Current: 3.98
1.96
4.2
PFCF 11.80
ALIOF's PFCF is ranked higher than
78% of the 129 Companies
in the Global Biotechnology industry.

( Industry Median: 30.73 vs. ALIOF: 11.80 )
ALIOF' s 10-Year PFCF Range
Min: 9.57   Max: 60.64
Current: 11.8
9.57
60.64
EV-to-EBIT 16.1
ALIOF's EV-to-EBIT is ranked higher than
58% of the 266 Companies
in the Global Biotechnology industry.

( Industry Median: 21.21 vs. ALIOF: 16.1 )
ALIOF' s 10-Year EV-to-EBIT Range
Min: 7.9   Max: 272.5
Current: 16.1
7.9
272.5

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 291
ALIOF's Price/Net Current Asset Value is ranked lower than
90% of the 313 Companies
in the Global Biotechnology industry.

( Industry Median: 41.90 vs. ALIOF: 291 )
ALIOF' s 10-Year Price/Net Current Asset Value Range
Min: 3.8   Max: 396
Current: 291
3.8
396
Price/Tangible Book 5.9
ALIOF's Price/Tangible Book is ranked lower than
56% of the 344 Companies
in the Global Biotechnology industry.

( Industry Median: 4.90 vs. ALIOF: 5.9 )
ALIOF' s 10-Year Price/Tangible Book Range
Min: 1.8   Max: 16.9
Current: 5.9
1.8
16.9
Price/Median PS Value 1.3
ALIOF's Price/Median PS Value is ranked lower than
65% of the 345 Companies
in the Global Biotechnology industry.

( Industry Median: 1.10 vs. ALIOF: 1.3 )
ALIOF' s 10-Year Price/Median PS Value Range
Min: 0.7   Max: 1.3
Current: 1.3
0.7
1.3
Price/Graham Number 2.4
ALIOF's Price/Graham Number is ranked higher than
51% of the 140 Companies
in the Global Biotechnology industry.

( Industry Median: 2.50 vs. ALIOF: 2.4 )
ALIOF' s 10-Year Price/Graham Number Range
Min: 0.6   Max: 6.2
Current: 2.4
0.6
6.2
Earnings Yield (Greenblatt) 6.20
ALIOF's Earnings Yield (Greenblatt) is ranked higher than
78% of the 392 Companies
in the Global Biotechnology industry.

( Industry Median: 0.70 vs. ALIOF: 6.20 )
ALIOF' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.4   Max: 12.6
Current: 6.2
0.4
12.6

Business Description

Actelion Limited is an independent, profitable, biopharmaceutical company discovering, developing and marketing drugs for high unmet medical needs.
Company Website
Industry: Biotechnology
Compare:
Traded in other countries:ATLNE.Switzerland, ATLN.Switzerland, ACT.Germany
ยป More Articles for OTCPK:ALIOF

Headlines

Articles On GuruFocus.com

More From Our Partners
Positive Data on Bayer Candidate - Analyst Blog May 23 2013 - ZACKS

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial